IPB

Üdvözöllek a Fórumban! ( Bejelentkezés | Regisztráció )

 
Reply to this topicStart new topic
China to use mRNA vaccine developed by Biotech to boost immunity
limited
hozzászólás Jul 20 2021, 08:20 AM
Létrehozva: #1


Advanced Member
***

Csoport: Members
Hozzászólások: 124
Csatlakozott: 30-January 21
Azonosító: 1,471







Biotech Vaccines It may be the first foreign vaccine approved for use in China.

A Chinese advisory panel has green lighted a pg slot COVID-19 vaccine developed by Bio-Tech, meaning it will become the first vaccine developed overseas. to be used in China Once approved by drug regulators

If the National Medical Products Commission Follow the recommendations of the said committee. The Comerneti branded vaccine will become the first vaccine based on state-of-the-art mRNA technology to be sold in China.

Mr. Wu Yifang, Chief Executive Officer of Fosun Pharma, which has been granted the right to distribute vaccines in China. said at the shareholders' meeting that The audit process went smoothly. According to the report of Kaisin magazine

Mr Wu also said that “Our communication with the National Medical Products Administration has been smooth. And the officers are racing against the time to check.”

The Biotech vaccine is now available in Hong Kong. This accounts for more than half of the 4.58 million doses of vaccines.

The report stated that Foshan prepares a factory in Shanghai to begin supplying vaccines to China along with citing one source who said These vaccines will be used as a booster for those who have already received a vaccine made in China. The Chinese government will give it to the people free of charge.

However, it is unclear when regulators will allow people to receive Biotech's first dose of vaccine. While Fosun and Biotech have yet to answer any questions.
Go to the top of the page
 
+Quote Post

Fast ReplyReply to this topicStart new topic
1 felhasználó olvassa jelenleg ezt a témát (1 vendég és 0 anonim felhasználó)
0 felhasználó:

 



Szöveges verzió A pontos idő: 6th November 2024 - 04:02 PM